The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial

  1. Lookup NU author(s)
  2. Dr Penelope Taylor
  3. Dr Brian Angus
  4. Professor Graham Jackson
  5. Dr Helen Lucraft
  6. Professor Stephen Proctor
Author(s)Taylor, P. R. A., White, J. M., Prescott, R. J., Angus, B., Galloway, M. J., Jackson, G. H., Lessells, A. M., Lucraft, H. H., Summerfield, G. P., Proctor, S. J.
Publication type Article
JournalLeukemia and Lymphoma
Year2006
Volume47
Issue11
Pages2321-2330
ISSN (print)1042-8194
ISSN (electronic)1029-2403
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
URLhttp://dx.doi.org/10.1080/10428190600881256
DOI10.1080/10428190600881256
PubMed id17107904
Actions    Link to this publication